The GI360 is a smart, evidenced-based stool test that is easily actionable by the clinician. Listen to my conversation today with VP of Scientific Support from Doctor’s Data, Dr. David Quig. One of the most useful tools I am aware of in stool testing is the Dysbiosis Test, which identifies and characterizes more than 45 targeted analytes across six Phyla using PCR and compares the patient results to a characterized normobiotic reference population. DDI is also using the Luminex PCR panel for pathogens, parasites and viruses – an FDA cleared panel for accurate detection of microbes that are almost always a problem. But what if they are not? Hear my discussion with Dr. Q on that. Finally, beta glucuronidase – it’s SO MUCH more complex than we’ve understood. Yes, we’re aware of the estrogen connection, but the BG story has evolved. We also walk through the chemistries – DDI includes a wide range of chems (appreciated by me and my colleagues here in our practice!). Give a listen, and leave us a review wherever you listen to New Frontiers! Thank you! ~DrKF
Methylation and sulfuration are complex processes and assessing them in practice takes skill, knowledge, and consideration of multiple genes and other factors. Lucky for us, we have the incredible Dr. David Quig from Doctor’s Data on the podcast today, getting into the nitty-gritty about assessing methylation in clinical practice.
If you’re riveted by the world of methylation, as we all are since the explosion of epigenetic research prompted a big rethink of our approach to treatment, you’re going to appreciate this smart blog from David Quig, PhD, VP of Scientific Affairs at Doctor’s Data, Inc.